- Home
- GALT vs RMR Comparison
GALT vs RMR Comparison
Compare GALT & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | RMR |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 350.2M |
| IPO Year | 2008 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GALT | RMR |
|---|---|---|
| Price | $4.01 | $18.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.50 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 301.3K | 71.8K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.37% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $700,284,000.00 |
| Revenue This Year | N/A | $259.61 |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | ★ N/A | $19.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $14.27 |
| 52 Week High | $7.13 | $21.45 |
Technical Indicators
Market Signals| Indicator | GALT | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 40.20 |
| Support Level | $2.74 | $17.88 |
| Resistance Level | $4.35 | $20.52 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 35.08 | 24.17 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About RMR The RMR Group Inc.
The RMR Group Inc is a U.S. based real estate investment manager engaged in commercial real estate, private capital, and credit strategies. Its portfolio covers various commercial real estate asset classes, and it manages investments across various industries, geographies and asset classes.